CA2407737A1 - Regulatory nucleic acid for the abc1 gene, molecules modifying its activity and therapeutic uses - Google Patents

Regulatory nucleic acid for the abc1 gene, molecules modifying its activity and therapeutic uses Download PDF

Info

Publication number
CA2407737A1
CA2407737A1 CA002407737A CA2407737A CA2407737A1 CA 2407737 A1 CA2407737 A1 CA 2407737A1 CA 002407737 A CA002407737 A CA 002407737A CA 2407737 A CA2407737 A CA 2407737A CA 2407737 A1 CA2407737 A1 CA 2407737A1
Authority
CA
Canada
Prior art keywords
nucleic acid
nucleotide
isolated nucleic
polynucleotide
transcription
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002407737A
Other languages
English (en)
French (fr)
Inventor
Marie-Francoise Rosier-Montus
Catherine Prades
Cendrine Lemoine
Laurent Naudin
Patrice Denefle
Bryan Brewer
Nicolas Duverger
Alan Remaley
Silvia Santamarina-Fojo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2407737A1 publication Critical patent/CA2407737A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002407737A 2000-05-02 2001-05-02 Regulatory nucleic acid for the abc1 gene, molecules modifying its activity and therapeutic uses Abandoned CA2407737A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20128000P 2000-05-02 2000-05-02
US60/201,280 2000-05-02
PCT/EP2001/005488 WO2001083746A2 (en) 2000-05-02 2001-05-02 Regulatory nucleic acid sequences of the abc1 gene

Publications (1)

Publication Number Publication Date
CA2407737A1 true CA2407737A1 (en) 2001-11-08

Family

ID=22745217

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002407737A Abandoned CA2407737A1 (en) 2000-05-02 2001-05-02 Regulatory nucleic acid for the abc1 gene, molecules modifying its activity and therapeutic uses

Country Status (14)

Country Link
US (1) US7378274B2 (pt)
EP (1) EP1280911A2 (pt)
JP (1) JP2003531613A (pt)
KR (1) KR20020097242A (pt)
AU (1) AU785155B2 (pt)
BR (1) BR0110541A (pt)
CA (1) CA2407737A1 (pt)
FR (1) FR2809414B1 (pt)
IL (1) IL152548A0 (pt)
MX (1) MXPA02010684A (pt)
NO (1) NO20025265L (pt)
NZ (1) NZ522360A (pt)
WO (1) WO2001083746A2 (pt)
ZA (1) ZA200208847B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60035163T2 (de) 1999-03-15 2008-02-21 University Of British Columbia, Vancouver Abc1 polypeptide und verfahren und reagenzien zur modulation des cholesterolgehalts
EP1854880A1 (en) * 1999-03-15 2007-11-14 University of British Columbia Methods and reagents for modulating cholesterol levels
US6821774B1 (en) 1999-06-18 2004-11-23 Cv Therapeutics, Inc. Compositions and methods for increasing cholesterol efflux and raising HDL using ATP binding cassette transporter ABC1
US6835563B1 (en) * 1999-06-18 2004-12-28 Cv Therapeutics Compositions and methods for increasing cholesterol efflux and raising HDL ATP binding cassette transporter protein ABC1
CN100513570C (zh) * 1999-06-18 2009-07-15 Cv治疗公司 结合框运输蛋白abc1的调节作用
CA2382562A1 (en) * 1999-09-01 2001-03-08 University Of British Columbia Compositions and methods for modulating hdl cholesterol and triglyceride levels

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5872237A (en) * 1996-04-04 1999-02-16 Mercator Genetics, Inc. Megabase transcript map: novel sequences and antibodies thereto
DE60035163T2 (de) * 1999-03-15 2008-02-21 University Of British Columbia, Vancouver Abc1 polypeptide und verfahren und reagenzien zur modulation des cholesterolgehalts
CN100513570C (zh) 1999-06-18 2009-07-15 Cv治疗公司 结合框运输蛋白abc1的调节作用
CA2382562A1 (en) * 1999-09-01 2001-03-08 University Of British Columbia Compositions and methods for modulating hdl cholesterol and triglyceride levels
US6773893B1 (en) * 2000-04-28 2004-08-10 The Trustees Of Columbia University In The City Of New York Human ABC1 promoter and assays based thereon

Also Published As

Publication number Publication date
US20020146792A1 (en) 2002-10-10
FR2809414B1 (fr) 2007-08-31
KR20020097242A (ko) 2002-12-31
AU785155B2 (en) 2006-10-05
IL152548A0 (en) 2003-05-29
EP1280911A2 (en) 2003-02-05
NO20025265D0 (no) 2002-11-01
AU6595601A (en) 2001-11-12
FR2809414A1 (fr) 2001-11-30
NO20025265L (no) 2002-12-18
BR0110541A (pt) 2003-04-01
MXPA02010684A (es) 2003-03-10
JP2003531613A (ja) 2003-10-28
NZ522360A (en) 2004-12-24
WO2001083746A3 (en) 2002-06-27
WO2001083746A2 (en) 2001-11-08
US7378274B2 (en) 2008-05-27
ZA200208847B (en) 2004-02-09

Similar Documents

Publication Publication Date Title
US7919091B2 (en) Lipolysis stimulated receptor (LSR) specific antibodies
EP1100895B1 (en) Abc1 polypeptide and methods and reagents for modulating cholesterol levels
Kaneto et al. PDX-1/VP16 fusion protein, together with NeuroD or Ngn3, markedly induces insulin gene transcription and ameliorates glucose tolerance
DE69626132T2 (de) Regulierung von essgewohnheiten
WO2001015676A9 (en) Compositions and methods for modulating hdl cholesterol and triglyceride levels
EP0988379A1 (en) Ldl-receptor
US6355782B1 (en) Hypohidrotic ectodermal dyplasia genes and proteins
US20020146792A1 (en) Regulatory nucleic acid for the ABC1 gene, molecules modifying its activity and therapeutic uses
JP2003523177A (ja) ヒトabc1遺伝子の核酸、並びに治療及び予防へのそれらの適用
KR20020012279A (ko) 인간 유전자 에이비씨1에 상응하는 핵산 및 단백질
JP2002300891A (ja) 新規化合物
US20030023991A1 (en) Hypohidrotic ectodermal dysplasia genes and proteins
US20030077591A1 (en) Nucleic acid for regulating the ABCA7 gene, molecules modulating its activity and therapeutic applications
JP2004512045A (ja) Abca7遺伝子を調節する核酸、その活性をモジュレートする分子および治療用途
AU2007240161A1 (en) Nucleic acid generating the ABCA7 gene, molecular modulating its activity and therapeutic applications
US20030176649A1 (en) Vmglom gene and its mutations causing disorders with a vascular component
FR2822165A1 (fr) Acide nucleique regulateur du gene abca7, molecules modulant son activite et applications therapeutiques

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued